Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Blood Advances|August 23, 2021
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiencyMatteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, et al.
Nature Communications|November 18, 2018
Demographic histories and genetic diversity across pinnipeds are shaped by human exploitation, ecology and life-historyM A Stoffel, E Humble, A J Paijmans, et al.
European Stroke Journal|February 17, 2025
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patientsAurora Semerano, Beatrice Dell'Acqua, Angela Genchi, et al.
AJNR. American Journal of Neuroradiology|December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical ApplicationsAli Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene TherapyRaisa Jofra Hernández, Andrea Calabria, Francesca Sanvito, et al.
Nature Communications|October 16, 2015
Liquid exfoliation of solvent-stabilized few-layer black phosphorus for applications beyond electronicsDamien Hanlon, Claudia Backes, Evie Doherty, et al.
Nature Ecology & Evolution|June 10, 2020
Determinants of genetic variation across eco-evolutionary scales in pinnipedsClaire R Peart, Sergio Tusso, Saurabh D Pophaly, et al.
Acta Neuropathologica Communications|February 2, 2022
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patientsAngela Genchi, Aurora Semerano, Ghil Schwarz, et al.
Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.
Science Translational Medicine|February 9, 2022
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell functionEliana Ruggiero, Erica Carnevale, Aaron Prodeus, et al.
Pageof 41